Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed Mar 31, 2023 · 10-K · 90 days after period end · 0001193125-23-088349
derived · Computed from the longer spans the company filed.
no prior Q4 2021 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
